1. Home
  2. AKBA vs XPOF Comparison

AKBA vs XPOF Comparison

Compare AKBA & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.22

Market Cap

251.0M

Sector

Health Care

ML Signal

HOLD

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$6.29

Market Cap

278.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
XPOF
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
251.0M
278.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
AKBA
XPOF
Price
$1.22
$6.29
Analyst Decision
Strong Buy
Hold
Analyst Count
3
6
Target Price
$4.67
$8.13
AVG Volume (30 Days)
4.1M
637.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
93.94
35.24
EPS
N/A
N/A
Revenue
N/A
$11,092,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$3.83
52 Week High
$3.81
$11.09

Technical Indicators

Market Signals
Indicator
AKBA
XPOF
Relative Strength Index (RSI) 46.66 42.03
Support Level $1.16 $5.33
Resistance Level $1.52 $7.11
Average True Range (ATR) 0.07 0.30
MACD -0.02 -0.11
Stochastic Oscillator 7.59 25.32

Price Performance

Historical Comparison
AKBA
XPOF

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

Share on Social Networks: